{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:21:50Z","timestamp":1793308910417,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.cld.2022.06.011","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T20:50:58Z","timestamp":1666126258000},"page":"691-704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Hepatocellular Carcinoma in Primary Biliary Cholangitis"],"prefix":"10.1016","volume":"26","author":[{"given":"Alexander M.","family":"Sy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphaella D.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binu V.","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cld.2022.06.011_bib1","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/hep.23095","article-title":"Incidence, risk factors, and survival of hepatocellular carcinoma in primary biliary cirrhosis: comparative analysis from two centers","volume":"50","author":"Cavazza","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2022.06.011_bib2","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1158\/0008-5472.CAN-06-1078","article-title":"Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor","volume":"67","author":"Yang","year":"2007","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.cld.2022.06.011_bib3","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.cld.2022.06.011_bib4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","article-title":"Epidemiology and management of hepatocellular carcinoma","volume":"156","author":"Kulik","year":"2019","journal-title":"Gastroenterology"},{"issue":"15","key":"10.1016\/j.cld.2022.06.011_bib6","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1200\/JCO.2015.64.7412","article-title":"Future of hepatocellular carcinoma incidence in the United States forecast through 2030","volume":"34","author":"Petrick","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cld.2022.06.011_bib7","first-page":"37","article-title":"FXR and liver carcinogenesis","volume":"36","author":"Huang","year":"2015","journal-title":"Nat Publ Gr"},{"key":"10.1016\/j.cld.2022.06.011_bib8","article-title":"Suppression of hepatic bile acid synthesis by a non-tumorigenic FGF19 analogue protects mice from fibrosis and hepatocarcinogenesis","volume":"8","author":"Gadaleta","year":"2018","journal-title":"Scientific Rep"},{"key":"10.1016\/j.cld.2022.06.011_bib9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41575-020-00404-2","article-title":"The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer","volume":"18","author":"Sun","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2022.06.011_bib10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1053\/j.gastro.2018.04.032","article-title":"Mechanisms of MAFG dysregulation in cholestatic liver injury and development of liver cancer","volume":"155","author":"Liu","year":"2018","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2022.06.011_bib11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/ijc.31835","article-title":"Associations between autoimmune conditions and hepatobiliary cancer risk among elderly US adults","volume":"144","author":"McGee","year":"2019","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.cld.2022.06.011_bib12","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s10620-020-06498-7","article-title":"Incidence of hepatocellular carcinoma in primary biliary cholangitis: a systematic review and meta-Analysis","volume":"66","author":"Natarajan","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.cld.2022.06.011_bib13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/gutjnl-2014-308351","article-title":"Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study","volume":"65","author":"Trivedi","year":"2016","journal-title":"Gut"},{"issue":"14","key":"10.1016\/j.cld.2022.06.011_bib14","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2169\/internalmedicine.52.0010","article-title":"Risk factors for survival and the development of hepatocellular carcinoma in patients with primary biliary cirrhosis","volume":"52","author":"Tomiyama","year":"2013","journal-title":"Intern Med"},{"issue":"2\u20133","key":"10.1016\/j.cld.2022.06.011_bib15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12016-015-8483-x","article-title":"Incidence and risk factors for hepatocellular carcinoma in primary biliary cirrhosis","volume":"48","author":"Rong","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.cld.2022.06.011_bib16","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/hep.26176","article-title":"Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: national data from Japan","volume":"57","author":"Harada","year":"2013","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2022.06.011_bib17","first-page":"1495","article-title":"Relatively high risk for hepatocellular carcinoma in patients with primary biliary cirrhosis not responding to ursodeoxycholic acid","volume":"22","author":"Kuiper","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2022.06.011_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/MEG.0b013e3282f163ed","article-title":"Risk of hepatocellular carcinoma and extrahepatic malignancies in primary biliary cirrhosis","volume":"20","author":"Deutsch","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2022.06.011_bib19","first-page":"1160","article-title":"Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-related cirrhosis","volume":"96","author":"Caballer\u00eda","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2022.06.011_bib20","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1053\/jhep.2002.33157","article-title":"Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis","volume":"35","author":"Shibuya","year":"2002","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2022.06.011_bib21","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.3748\/wjg.v21.i12.3554","article-title":"Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors","volume":"21","author":"Zhang","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2022.06.011_bib22","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1568-9972(02)00050-2","article-title":"Primary biliary cirrhosis and hepatocellular carcinoma","volume":"1","author":"Findor","year":"2002","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.cld.2022.06.011_bib23","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.510260508","article-title":"Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes","volume":"26","author":"Jones","year":"1997","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2022.06.011_bib24","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cgh.2017.02.006","article-title":"Incidence and determinants of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis","volume":"15","author":"Tansel","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2022.06.011_bib25","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hep.510290301","article-title":"Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis","volume":"29","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cld.2022.06.011_bib26","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.14309\/ajg.0000000000001280","article-title":"Ursodeoxycholic acid response is associated with reduced mortality in primary biliary cholangitis with compensated cirrhosis","volume":"116","author":"John","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2022.06.011_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bpg.2018.06.002","article-title":"Patterns of disease progression and incidence of complications in primary biliary cholangitis","volume":"34-35","author":"Janmohamed","year":"2018","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2022.06.011_bib28","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.jhep.2015.06.031","article-title":"Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis","volume":"63","author":"Beuers","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2022.06.011_bib29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cld.2018.03.001","article-title":"Changes in the epidemiology of primary biliary cholangitis","volume":"22","author":"Lleo","year":"2018","journal-title":"Clin Liver Dis"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2022.06.011_bib30","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000315247","article-title":"Gender disparity of hepatocellular carcinoma: the roles of sex hormones","volume":"78","author":"Yeh","year":"2010","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.cld.2022.06.011_bib31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cgh.2006.09.031","article-title":"Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis","volume":"5","author":"Suzuki","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Suppl 3","key":"10.1016\/j.cld.2022.06.011_bib32","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1093\/infdis\/jiu057","article-title":"Natural history and management of hepatitis C: does sex play a role?","volume":"209","author":"Baden","year":"2014","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cld.2022.06.011_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ypmed.2015.06.009","article-title":"A\u00a0literature review on prevalence of gender differences and intersections with other vulnerabilities to tobacco use in the United States, 2004-2014","volume":"80","author":"Higgins","year":"2015","journal-title":"Prev Med"},{"issue":"2","key":"10.1016\/j.cld.2022.06.011_bib35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3748\/wjg.15.231","article-title":"Features of hepatocellular carcinoma in cases with autoimmune hepatitis and primary biliary cirrhosis","volume":"15","author":"Watanabe","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2022.06.011_bib36","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/hep.510290501","article-title":"Hepatic and extrahepatic malignancies in primary biliary cirrhosis","volume":"29","author":"Floreani","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.011_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/610504","article-title":"Sex differences associated with primary biliary cirrhosis","volume":"2012","author":"Smyk","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"2","key":"10.1016\/j.cld.2022.06.011_bib38","first-page":"266","article-title":"Increased cancer risk in a large population-based cohort of patients with primary biliary cirrhosis: follow-up for up to 36 years","volume":"8","author":"Boonstra","year":"2014","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cld.2022.06.011_bib39","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2147\/CMAR.S188238","article-title":"Type 2 diabetes mellitus increases the risk of hepatocellular carcinoma in subjects with chronic hepatitis B virus infection: a meta-analysis and systematic review","volume":"11","author":"Tan","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"2","key":"10.1016\/j.cld.2022.06.011_bib40","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s10620-015-3983-3","article-title":"Diabetes Mellitus increases risk of hepatocellular carcinoma in chronic hepatitis C virus patients: a systematic review","volume":"61","author":"Dyal","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.cld.2022.06.011_bib41","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12916-019-1321-x","article-title":"Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts","volume":"17","author":"Alexander","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.cld.2022.06.011_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/168012","article-title":"Incidence, mortality, and predictive factors of hepatocellular carcinoma in primary biliary cirrhosis","volume":"2013","author":"Hosonuma","year":"2013","journal-title":"Gastroenterol Res Pract"},{"issue":"2","key":"10.1016\/j.cld.2022.06.011_bib43","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2022.06.011_bib44","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2022.06.011_bib45","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"issue":"6","key":"10.1016\/j.cld.2022.06.011_bib46","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","article-title":"Surveillance imaging and alpha fetoprotein for early Detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis","volume":"154","author":"Tzartzeva","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2022.06.011_bib47","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2022.06.011_bib48","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cgh.2011.09.013","article-title":"Long-term outcomes of patients with primary biliary cirrhosis and hepatocellular carcinoma","volume":"10","author":"Imam","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2022.06.011_bib49","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/TP.0b013e31827afb3a","article-title":"Evolving frequency and outcomes of liver transplantation based on etiology of liver disease","volume":"95","author":"Singal","year":"2013","journal-title":"Transplantation"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:00:18Z","timestamp":1761069618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326122000496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1089326122000496"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2022.06.011","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatocellular Carcinoma in Primary Biliary Cholangitis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2022.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}